Capital Rx

Capital Rx

Private
New York City, New YorkHealthcare & Life Scienceswww.cap-rx.com

Last Round

Series F

Sep 23, 2025

Est. Valuation

$3.25B

Total Funding Raised

$333M

Momentum Score

25 /100

Company Overview

Capital Rx is a healthcare technology company that offers an enterprise pharmacy platform aimed at transforming prescription drug pricing and enhancing patient services by integrating all facets of the pharmacy ecosystem to boost patient engagement and operational efficiency.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Vertical SaaS, InsurTech, Revenue Cycle, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Payment Processing Fee, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

pharmacy benefit managerPBMJudi Healthhealth benefits platformdrug price transparencytransparent PBMPBM disruptorpharmacy benefit administratorPBAclaims adjudicationflat-fee PBMenterprise health platformNADACAI-powered health benefitsMedicare plansMedicaid plansprescription discount card

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Capital Rx Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Capital Rx Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series FSep 23, 2025
Series DMar 28, 2024
StrategicOct 11, 2023
Series CJun 13, 2022
Series BFeb 2, 2021
Series A
Jul 16, 2019

Key People

Founding team and executive leadership

Ryan Kelly

CTO

Executive Team

Capital Rx Investors

Notable investors and investment history

InvestorRounds
Novant HealthStrategic
Edison PartnersSeries B, Series F, Series C, Series A
Emerald Development ManagersSeries A
Ochsner VenturesStrategic
B Capital GroupSeries F, Series C
Atlantic Health SystemStrategic
Goldman Sachs Growth EquitySeries F

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Certified B Corp™ status disclosed in job posting.

  • Mar 3, 2026

    Judi platform services millions across Medicare, Medicaid, and commercial plans.

Capital Rx Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Capital Rx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Capital Rx's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range782
Year Founded2017
Last FundingSep 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.